Board Change • May 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. 1 independent director (2 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Anuncio • Mar 17
Nano Chem Tech Inc., Annual General Meeting, Mar 31, 2026 Nano Chem Tech Inc., Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: auditorium, 112, yangseong-ro, yangseong-myeon, gyeonggi-do, anseong South Korea Anuncio • Jan 24
Pume PEF 1 agreed to acquire 6.68% stake in CANVAS N Co.,Ltd. (KOSDAQ:A210120) from Nano Chem Tech Inc. (KOSDAQ:A091970) for KRW 7.9 billion. Pume PEF 1 agreed to acquire 6.68% stake in CANVAS N Co.,Ltd. (KOSDAQ:A210120) from Nano Chem Tech Inc. (KOSDAQ:A091970) for KRW 7.9 billion on January 22, 2026.
The expected completion of the transaction is February 13, 2026. New Risk • Oct 02
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 10.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (10.0% average weekly change). Market cap is less than US$100m (₩25.9b market cap, or US$18.5m). Anuncio • Mar 13
Nano Chem Tech Inc., Annual General Meeting, Mar 26, 2025 Nano Chem Tech Inc., Annual General Meeting, Mar 26, 2025, at 09:00 Tokyo Standard Time. Location: auditorium, 112, yangseong-ro, yangseong-myeon, gyeonggi-do, anseong South Korea Valuation Update With 7 Day Price Move • Feb 17
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩572, the stock trades at a trailing P/E ratio of 23.1x. Average trailing P/E is 11x in the Chemicals industry in South Korea. Total loss to shareholders of 32% over the past year. Anuncio • Feb 06
CANVAS N Co.,Ltd. (KOSDAQ:A210120) agreed to acquire 29% stake in Hanil Oneex Co., Ltd. from Nano Chem Tech Inc. (KOSDAQ:A091970) for KRW 4.8 billion. CANVAS N Co.,Ltd. (KOSDAQ:A210120) agreed to acquire 29% stake in Hanil Oneex Co., Ltd. from Nano Chem Tech Inc. (KOSDAQ:A091970) for KRW 4.8 billion on February 4, 2025. A cash consideration of KRW 4.79 billion will be paid by CANVAS N Co.,Ltd. As part of consideration, KRW 4.79 billion is paid towards common equity of Hanil Oneex Co., Ltd. The expected completion of the transaction is June 30, 2025. New Risk • Dec 16
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Market cap is less than US$100m (₩24.7b market cap, or US$17.2m). New Risk • Dec 07
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended December 2009. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2009 fiscal period end). Minor Risk Market cap is less than US$100m (₩24.6b market cap, or US$17.3m). New Risk • Dec 03
New major risk - Financial position The company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (currently running at an operating cash loss). Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (₩25.9b market cap, or US$18.5m). Valuation Update With 7 Day Price Move • Dec 03
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to ₩717, the stock trades at a trailing P/E ratio of 28.9x. Average trailing P/E is 9x in the Chemicals industry in South Korea. Total loss to shareholders of 32% over the past year. Anuncio • Oct 30
Nano Chem Tech Inc. announced that it expects to receive KRW 3 billion in funding Nano Chem Tech Inc. announced a private placement to issue 5% Series 11 Bearer Interest Unsecured Private Placement Convertible Bonds due February 28, 2028 for the gross proceeds of KRW 3,000,000,000, 5% Series 10 Bearer Interest Unsecured Private Placement Convertible Bonds due February 28, 2028 for the gross proceeds of KRW 3,000,000,000; aggregate gross proceeds of KRW 6,000,000,000on October 28, 2024. The transaction will include participation from returning investor Kasa Investment Co., Ltd. The transaction has been approved by shareholders, restricted to a hold period, expected to close on February 28, 2025 bears 5% coupon rate, 6% maturity rate and matures on February 28, 2028, 100% convertible into 4,615,384 shares at a fixed conversion price of KRW 650 from February 2, 2026 to January 28, 2028. New Risk • Oct 11
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 34% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Shareholders have been diluted in the past year (35% increase in shares outstanding). Market cap is less than US$100m (₩36.7b market cap, or US$27.4m). Anuncio • Jul 12
Nano Chem Tech Inc. announced that it has received KRW 10 billion in funding from Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd. On July 11, 2023, Nano Chem Tech Inc. closed the transaction. Board Change • Feb 28
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. 1 independent director (2 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.